Endocyte Pursuing Phase 3 Trial of 177Lu-PSMA-617 in Metastatic PC – Prostate Cancer News Today
Prostate Cancer News Today |
Endocyte Pursuing Phase 3 Trial of 177Lu-PSMA-617 in Metastatic PC
Prostate Cancer News Today “With the exception of a very targeted effort to generate proof-of-concept data for our CAR T-cell program, we will focus our resources on the development of 177Lu-PSMA-617. We will explore out-licensing opportunities for all other development programs … |
